These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7984878)

  • 1. Taxol--new hope for cancer patients.
    Fox SM; Haney LG
    RN; 1994 Nov; 57(11):33-6. PubMed ID: 7984878
    [No Abstract]   [Full Text] [Related]  

  • 2. Taxol administration.
    Rutherford C
    J Intraven Nurs; 1994; 17(3):139-43. PubMed ID: 7914922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What you need to know about Taxol.
    Lilley LL; Scott HB
    Am J Nurs; 1993 Dec; 93(12):46-50. PubMed ID: 7905707
    [No Abstract]   [Full Text] [Related]  

  • 4. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol: a case study.
    DeLaPena LB; Pyron S; Nichols J
    Cancer Nurs; 1993 Dec; 16(6):423-30. PubMed ID: 7906612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
    Mayerhofer K; Kucera E; Zeisler H; Speiser P; Reinthaller A; Sevelda P
    Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel (taxol) for ovarian cancer.
    Med Lett Drugs Ther; 1993 May; 35(896):39-40. PubMed ID: 8097551
    [No Abstract]   [Full Text] [Related]  

  • 8. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Taxol--a novel experimental drug for the treatment of ovarian cancer].
    Menczer J
    Harefuah; 1993 Jan; 124(1):28-30. PubMed ID: 8094702
    [No Abstract]   [Full Text] [Related]  

  • 10. Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group.
    Ezcurdia L; Jovtis SL; Mickiewicz E; Temperley G; Rondinón M; Blajman C; Cóppola FS; Lewi D; Cazap E; Breier S; Fasce H; Fein L; Polera J; Triguboff E; Uranga G; Pasccón G; Luchina AM; Martínez CA; Politi PM; Rubio G; Alvarez AM
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-53-S15-56. PubMed ID: 9346223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment for ovarian cancer poses ecology dilemma.
    Crumbie A
    Nurs Times; 1994 Jun 15-21; 90(24):34-5. PubMed ID: 7913219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of ovarian and breast cancer with Taxol].
    Dtsch Med Wochenschr; 1996 Dec; 121(50 Suppl):1-12. PubMed ID: 9022362
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paclitaxel (Taxol)--drug of choice in ovarian cancer].
    Fishman A
    Harefuah; 1996 Apr; 130(8):557-60. PubMed ID: 8765885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Second-line chemotherapy with paclitaxel for ovarian cancer].
    Lehoczky O; Bagaméri A; Udvary J; Pulay T
    Orv Hetil; 2001 Oct; 142(42):2299-301. PubMed ID: 11760646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NICE approves Taxol for ovarian cancer.
    Kmietowicz Z
    BMJ; 2000 May; 320(7245):1293. PubMed ID: 10807610
    [No Abstract]   [Full Text] [Related]  

  • 16. [Second-line chemotherapy for ovarian cancer: the potential of Taxol].
    Maksimov SIa
    Vopr Onkol; 2002; 48(1):99-101. PubMed ID: 12101579
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new cytostatic agent: Taxol].
    Uitterhoeve RJ
    TVZ; 1994 Apr; 104(7):223-6. PubMed ID: 7915524
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
    Lehoczky O; Bagaméri A; Udvary J; Pulay T
    J Obstet Gynaecol; 2002 May; 22(3):312-3. PubMed ID: 12521509
    [No Abstract]   [Full Text] [Related]  

  • 19. Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study.
    ten Bokkel Huinink W; Veenhof C; Huizing M; Rodenhuis S; Helmerhorst T; Dubbelman R; Dalesio O; Beijnen J; Winograd B
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-31-S2-33. PubMed ID: 9045333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.